SlideShare uma empresa Scribd logo
1 de 135
As is our Pathology,
so is our Practice.
-- Sir William Osler, M.D.
(Father of Modern Medicine & Founding professor of John Hopkins,
developed first residency program for physicians.)
Pathology: The science of medicine !
CPC21: Week Overview
2013 Term 2 CPC 1 Title: Haematopoetic 1/2 Anaemia
System: Haematopoietic system
Aim: To train students in:
Clinical, pathological & population studies of patients with
anemia (RBC disorders)
Objectives: 1. History taking & clinical examination of patients with
anaemia
2. Physical examination for anaemia and related illnesses.
3. Pathophysiology of common and important rare causes of
anaemia, particularly in the tropics and Indigenous
populations.
4. Review of Basic sciences relating to bone marrow, red blood
cell production and turnover of iron, routine blood test
parameters, measurement of iron stores, and precursors
important for red cell production.
5. Pathophysiology of acute anaemic processes.
6. Complications of anaemia.
7. Anaemia as a presentation for other pathologies and as an
illness in itself.
Core Learning Issues:
• Basic Science Review:
–RBC life cycle, structure, functions.
–Iron, B12 & Folate, Hemoglobin/bilirubin metabolism.
• Major Learning:
–CBC – Principles & Interpretation (reticulocytes).
–Microcytic, Macrocytic & Normocytic anemia.
–Overview & Classification of Anemias
–Common An: IDA, MA, Hemolytic & ACD
•Minor Learning:
–Congenital anemia– sickle, thalassaemia, G6PD, HS.
–Aplastic and hypoplastic anemia.
–Disorders of excess RBC – Polycythemia.
–Myelodysplastic syndromes (refractory anemia).
3
Haemopoiesis:
4
Leukemia
5
Blood Smear - Normal
6
Lymphocyte
RBC
crenated RBC
Blood count - C.B.C / F.B.C
• Haemoglobin - 15±2.5, 14 ±2.5 - gms/dl.
• PCV/HCT - 0.47 ±0.07, 0.42 ±0.05 - lit/lit (%)
– RBC vol – better than Hb for anemia diagnosis.
• RBC count - 5.5 ±1, 4.8 ± 1 x1012/lit
• MCHC - Hb/PCV - 30-36 – grams/deci lit.
– Hb synthesis within RBC
• MCH - Hb/RBC - 29.5 ± 2.5 pg picogram (wt)
– Average Hb in RBC
• MCV - PCV/RBC 85 ± 8 – fl femto litres (vol)
7
30
33
85
Reticulocyte: Immature RBC
Reticular RNA - Methylene blue stain.
Reticulocyte
RBC
Reticulocytes (Immature RBC)  Increased RBC production
Reticulocytosis  Hemolytic anemia/bleeding 5-7 days
(Bluish, Large (high MCV)
MCV
Microcytic Normocytic Macrocytic
Measure Ferritin
Low Normal/high
Iron def
Anemia
Anemia of
chronic disease/
Congenital Hb dis.
Reticulocyte count
high low Anemia of chronic disease
Renal failure
Marrow failure
Hemolytic anemia
or blood loss
Measure B12 + folate
Megaloblastic
anemia
Normal Low
Anemia clinical
Types & Diagnosis
Haemopoiesis in Def. anemias
10
Iron Def. Anem Normal Megaloblastic
Normal DNA, Low Hb
More cell division
Micro-Normoblasts
Low DNA, Normal Hb
Less Cell division
Megaloblasts
Normal DNA & Hb
Normal cell division
Normoblasts
Macropoly, pancytopenia
IDA – Clinical Features
11
Bald Fissured - Glossitis
Angular chelitis
Pale creases
…Why?
Stages of Iron Deficiency:
12
Hypochromic Microcytic RBC
13
Megaloblastic Anaemia:
14
Marrow Hyperplasia Erythroblasts - Megaloblasts
Giant metamyelocyte - Macropolycyte Megaloblastic marrow
15
ANEMIA OF CHRONIC
DISEASE:
• Defective iron transfer.
• By Inflammatory
mediators.
•  erythropoietin
production.
•  Iron transfer.
• IDA with normal or
increased iron stores.
• Does not respond to
hematenic therapy.
• Responds to
erythropoietin or
resolution of
inflammation.
“The future belongs to those
who believe in the beauty of
their dreams.”
–Eleanor Roosevelt
Self-pity is an opiate!
--Napoleon Hill
Hemolytic anemia: Morphology
• Abnormal shapes
(here a spherocyte)
• Polychromatophil
(large, bluish, no central palor)
• Nucleated RBC
(small, pyknotic)
18
Thalassemia
Hemolytic Anemia - Types:
• Acquired/External causes:
– Immune Hemolytic Anemia
• Warm Antibody HA (WAHA) & Cold Ab (CAHA)
• Allo immune hemolytic anemia.
– Mechanical Damage
• Valve, Microangiopathy (DIC), prosthesis, march
– Infection induced
• Clostridia, malaria, septicemia
• Congenital/Internal Defects
• Membrane (Hereditary Spherocytosis)
• Enzyme defect (G6PD deficiency)
• Hb defects (Qual: Sickle cell dis, Quant: Thalassemias)
19
1
2
3
Commonest
Autoimmune Hemolytic An: AIHA
• Auto antibody binding to red
cell surface antigens / Drug
complex.
• RBC phagocytosis in spleen
or complement fixation and
intravascular hemolysis.
• Warm (IgG) & Cold (IgM)
types.
• Warm: Drugs, Ideopathic.
• Cold: Infections, Lymphoma
• Lab diagnosis: Coombs
Test, Direct / Indirect.
20
Warm / IgG
Cold / IgM
AIHA: Lab diagnosis – Coombs test.
21
Direct Coombs Test:
(for antigen on patient RBC)
Indirect Coombs Test:
(for antibodies in the serum.)
Pos
Neg
Sickle Cell Anemia - Pathology
Sickle Cell Anemia
• Commonest congenital hemolytic anemia.
• Hemoglobinopathy – β chain 6(ValGlu)  HbS
• Deoxigenation  cryst. Hb  rigid sickle  obstruction, hemolysis.
• BS - Sickle cells, anisocytosis, poikilocytosis, and target cells.
• Hemolytic anemia, Multiple Infarcts, autosplenectomy(adult),
pigment gall stones, hemosiderosis.
Thalassemia:
24
• Quantitative Hb defect.
• Defective protein chain
synthesis.
• α, β, , , … types.
• α thal  α  Hb   β (β
β or β tetramers)
• Decreased normal Hb.
• Abnormal Hb (α/β tetramers).
• Like IDA (minor) Destruction
 hemolytic anemia (major)
• Minor: micro hypo, target cells
• Major: severe with hemolysis.
Minor / Trait
Major / Disease
“The only person who never
makes a mistake is a person who
never does anything”
- Theodore Roosevelt
25
2013 Term 2 CPC 2 Title: Haematology 2/2
System: Haematopoetic System
Aim: To train students in:
Clinical and pathological presentation of haematological
malignancy
Objectives: 1. History taking & clinical examination of patients with
haematological malignancy
2. Physical examination of haematopoeitic system and related
systems in malignancy.
3. Pathophysiology of haematological malignancies.
4. Review of basic sciences relating to bone marrow, red blood
cell production and turnover of iron, routine blood test
parameters, measurement of iron stores, and precursors
important for red cell production.
5. Pathophysiology
6. Complications of haematological malignancies.
CPC22: Week Overview
27
Normal Blood Cells:
Neutrophil
Basophil
Eosinophil
Lymphocyte
Non granular, Mononuclears
Specific Immunity
Granulocytes, Polymorphs
Non-Specific Immunity
WBC Absolute counts in disease:
Penia Philia
Neutro
Penia Philia
Eosino
Penia cytosis
Mono
Penia cytosis
Lympho
Granulopoiesis – Leukocytosis – Shift to left
Leukemia Classification
• Acute Leukemias:
– Acute Myeloid Leukemia - AML
• AML M0, M1, M2, M3, M4, M5, M6 & M7
– Acute Lymphoid Leukemia - ALL
• ALL - L1, L2 & L3 - maturity
• Chronic Leukemias:
– Chronic Myeloid Leukemia- CML
• Eosinophilic, neutrophilic, myelomonocytic etc.
– Chronic Lymphoid Leukemia - CLL
• Myeloma, Hairy cell, prolymph, Sezary sy. etc.
ALL - AML
Leukemia - Clinical Features
Decreased Hemopoiesis:
• Anemia (low RBC)
• Fever - Infections (low WBC)
• Bleeding tendency (low PLT)
Organ Infiltration:
• Bone pain / back pain.
• Lymphadenopathy.
• Hepato-spleenomegaly.
ALL - AML
• Dense chromatin
• Few nucleoli
• Scanty cytoplasm.
• No cytoplasmic granules.
• Fine lacy chromatin
• Many nucleoli
• More cytoplasm
• Cytoplasmic granules
CML CLL
• Middle age 40-60y
• Philadelphia chrom. t(9:22)
• Anemia, Fever & Bleeding
• Marked leucocytosis –
>50,000 (abnormal)
• Marked splenomegaly,
Hepatomegaly.
• Elderly age
• Anemia, fever & bleeding
– slow over years.
• Lymphocytosis &
Lymphadenopathy
• Marked Spleenomegaly
• Common B cell (CD5 +ve)
Chronic phase Accelerated crisis
Clinical course 
Lymphoma
• Definition: Neoplasms of lymphoid tissue
• Etiology: Idiopathic, Genetic, Infective.
• Pathogenesis:
– overexpression of antiapoptotic gene
– t(14-18)  bcl-2+IgM.  B Lymph. neoplasia *
• Clinical: Lymphadenopathy, weight loss, Fever,
Anemia.
• Hodgkins lymphoma (HL) – RS cells.
• Non-Hodgkins lymphoma (NHL) – no RS.
– B, T & Histiocytic “B commonest”
Hodgkins Lymphoma:
• Only Reed-Sternberg cells are malignant ‘B’
cells. Others cells are reactive.
• Types:
• Nodular sclerosis HL
• Lymphocyte-rich classical HL
• Mixed cellularity HL
• Lymphocyte depletion HL
• More RS cells = poor prognosis.
• Progresses by continuity – nearby LN first.
• Staging is important for prognosis. (x NHL)
Hodgkins Lymphoma:
• B cell lymphoma with special RS cells.
• Only Reed-Sternberg cells are malignant
‘B’ lymphocytes. Others cells are mixed
inflammatory cells with eosinophils.
• Many sub types: based on % of RS cells.
• More RS cells = poor prognosis.
1. Lymphocyte-rich classical HL
2. Nodular sclerosis HL – commonest.
3. Mixed cellularity HL
4. Lymphocyte depletion HL
• Spread to nearby LN not distant.
• Good prognosis, cure likely*
RS
RS
RS
Non-Hodgkins Lymphoma:
• Large group of lymphatic malignancies.
• types B, T & Histiocytic. “B common”
• Clinical Features:
– Fever, anemia, infections,
– Lymphadenopathy. Spleen+/-.
– low, intermediate & high grade.
• Pathology
– Lymphnode tumour – no RS cells, all one type.
– Follicular / Diffuse, Small / Large / mix Cells.
• Special types:
– Burkitts lymphoma – lymphoblastic.
– Multiple Myeloma – plasma cell.
NHL types- Diffuse & Nodular types
Lymphoma: Hodgkins Non Hodgkins
Age Average age is 27.7 with
two peaks, 15-24y , >55.
Average age is about 67.
Occurrence ~ 15% of all lymphomas ~ 85% of all lymphomas
Location above the collar bone 85%
(the mediastinum),
Extranodal in 4%
Chest in 40%, more abdomen
(exception lymphoblastic
lymphoma)
Extranodal in ~23% & BM
Affected
Lymph
Cells
B-Lymphocytes
characterized by the
Reed-Sternberg Cell
B, T, Histiocytes, NK Cells
depending on the subtype
Symptoms More likely to have
systemic ("B") Symptoms
Less likely to have "B“
symptoms.(27%)
Progression Early diagnosis,
Predictable, continuous
involvement. Better prog.
Late stages, less predictable
more spread.
Good to Worse prognosis.
Burkitt’s lymphoma: B cell.
• Young children, EBV virus.
• Endemic in Africa
• High grade, fast growing,
• Tumour in jaw bones.
• Lymphoblastic lymphoma
• Many macrophages – “starry sky”
appearance.
Multiple Myeloma:
• Malignancy of Plasma cells (Mature
B lymphocytes with Ab production)
• Hyper gammaglobulinemia
• Monoclonal antibody – neoplastic.
• Thick viscous blood – infarctions,
visual difficulties & even blindness.
• Old age, males common.
• Multiple, punched out Lytic bone
lesions (Osteolysis) & fractures.
• Immunodeficiency – infections.
"Creativity is inventing,
experimenting, growing,
taking risks, breaking
rules, making mistakes,
and having fun."
-- Mary Lou Cook
MyeloProliferative Syndromes:
• Neoplastic, Proliferation, Slow, chronic, & Mature cells.
• JAK2 gene mutation on 9p*  Erythropoietin
hypersensitivity.
• Increased number (Functionally abnormal)
• Extramedullary spread – Hepatosplenomegaly.
• May transform to Acute Leukemia (AML).
• Classification:
– RBC - Polycythemia vera (PV)
– WBC
• Chronic Myeloid Leukemia (CML)
• Chronic neutrophilic leukemia
• Chronic eosinophilic leukemia/HE syndrome.
– PLT - Essential Thrombocythemia (ET)
– Fibroblasts - Myelofibrosis (MF)
ET - Blood Film & clinical.
Plenty of
Platelets
Megakaryocyte
Polycythemia Rubra Vera (PV)
Hypercellular Marrow,
Red skin & Hepatosplenomegaly
MPS : MF. Hepatosplenomegaly
Massive hepato-splenomegaly secondary to
Extramedullary hematopoiesis due to Myelofibrosis.
Myelodysplastic Syndromes:
• Excess proliferation & destruction of dysplastic cells in
BM  Peripheral pancytopenia.
• Also known as Refractory Anemia’s
FAB classification
RA : Refractory Anemia (BM Blasts <1%)
RARS : RA with Ring Sideroblasts (<1%)
RAEB : RA with excess blasts (<5%)
RAEB in T : RAEB in transformation (5-30%)
(>30% blasts in BM  Leukemia)
Abnormal cells &
Recurrent infections in MDS
Worrying is like a rocking
chair, it gives you
something to do, but
doesn't get you anywhere.
-- Anonymous.
….Instead.. join winners club….!
The goal of mankind is knowledge,
which is is inherent in man. No
knowledge comes from outside: it is all
inside. What man 'learns' is really what
he “discovers” by taking the cover off
his own soul.
Swami Vivekananda
Education… from Eduse (latin) to bring out..
2013 Term 2 CPC 3 Title: Hepatobiliary 1/2
System: Hepatobiliary System
Aim: To train students in:
Clinical Diagnosis & Understanding of patients with liver
disease.
Objectives:
(breakdown of
Aim)
1. History taking & clinical examination in patients with
liver disease.
2. Pathophysiology of acute & chronic hepatitis.
3. Pathophysiology of cirrhosis.
4. Review of basic sciences of hepatobiliary system.
5. Professional, ethical & legal issues in alcohol & drug
abuse.
6. Epidemiology of addiction, public health strategies.
CPC23: Week Overview
Note to tutors: There are two cases this week. Either case illustrates the learning issues.
Please feel free to use either case (or both).
52
Liver Function Tests: Interpretation
• Synthesis / Function.
– Total protein & albumin low,
PT?Hepatocyte Injury.
– ALT, AST, LDH - high. ??
– Alk Phos – mild increase??
• Bile Duct Damage:
– Alk Phos – increased ??
• Other:
– GGT – alcohol use. – why?
– Viral serology -
– Auto-Antibody panel.
GGT ↑ Alcohol (centrilobular)
IgG ↑ Autoimmune hepatitis
IgM ↑ Primary biliary cirrhosis
IgA ↑ Alcoholic cirrhosis
AFP +ve Hep. Cell. Carcinoma
Anti-
mitochondrial
antibody
+ve Primary biliary cirrhosis
Anti-smooth
muscle, & ANA
+ve Autoimmune hepatitis
53
• 1.5 kg, wedge shape
• 4 lobes, Right, left,
(Caudate, Quadrate)
• Double blood supply
• Hepatic arteries
• Portal – Venous blood
Normal
CPC 4.2.3 – 2013 – “yellow eyes”
• Fatigue / Anorexia..?
• Nausea, Vomiting..?
• Haematemesis… ?
• Itching..?
• Fever..?
• Abdominal distension slow..?
• Bleeding / Bruising..?
• 10 stubbies/day /more..?
• Many Tattoos..?
• BMI – if low / High..?
54
Mr. T.D. 50 year old, presents to his GP. ‘My stomach appears big
and my wife has noticed a yellow tinge in my eyes’.
CASE STUDY 1
Abd distension, fatigue, yellow discoloration of eyes for 1 week
Presenting Symptoms:
• Liver failure…
• Liver failure…
• Portal Hypertension
• Obstructive jaundice.
• Hepatitis.
• Cirrhosis.
• Vit-K deficiency.
• Alcoholic hepatitis.
• Viral Hepatitis (B/C)
• Anorexia / Obesity –
steatosis.
• Differential Diagnosis:
• Hepatitis: Alcoholic/Infective/Malignant/Drug/Toxins
• Acute / Chronic? Primary/Secondary?
• “HBV / HCV, CMV, Lepto, Dengue, Melioidosis.
55
Viral Hepatitis A: Serology
56
Viral Hepatitis B: Serology
Sequence of serologic markers for hepatitis B viral hepatitis demonstrating (A)
acute infection with resolution and (B) progression to chronic infection.
57
Pathogenesis of Hepatitis A & B:
58
Acute Hepatitis:
• Portal & Diffuse Inflammation.
• No clear border between inflammation & normal tissue
• Because of active necrosis & apoptosis at margins.
• Abnormal enzymes.
59
Liver Biopsy – Chronic
Inflammation
• Portal Inflammation.
• No Necrosis
• Liver enzymes normal
60
Acute viral Hepatitis: Swelling & Apoptotic cells.
• Diffuse Inflammation.
• Necrosis & Apoptosis.
• Liver enzymes raised.
61
Fulminant Hepatitis:
• Rapid Hepatic failure with in 2-3 weeks.
• Massive necrosis, shrinkage, wrinkled
• Only portal tracts visible
• Little or massive inflammation – time
• Complete recovery – or - cirrhosis.
62
Clinical Spectrum of HBV inf:
Acute
Chronic
63
Cirrhosis – Portal hypertension
1. Cirrhosis-obstruction
2. Portal hypertension
3. Splenomegaly
4. transudation - Ascites
64
Liver Biopsy – Cirrhosis
Reg. nodule
Fibrous septa
Primary Biliary Cirrhosis
• Autoimmune.
• Females 6:1.
• Pruritis, jaundice,
hepatosplenomegaly (initial).
• Intrahepatic Bile duct inflammation
• Cholestasis (bile stained liver)
65
"The past, the present and the
future are really one: they are
today!"
-Harriet Beecher Stowe
The past has gone and future you cannot see. The present, when you can do something, that is the Gift
(Present) with which you can make your future & past memorable.
- Sai Baba
67
Chronic Alcoholism:
Acetaldehyde
68
Alcoholic Liver Damage
69
Alcoholic Hepatits - Mallory's hyalin
70
Alcoholic Fatty Liver
71
Alcoholic Fatty liver:
72
High Risk
Intermediate
Low Risk
Safe drinking…
73
Learn from the mistakes
of others. You can't live
long enough to make
them all yourself…!
61% of 5th year students exceeded ‘sensible’ limits
Drugs and alcohol were taken mainly for pleasure and were
perceived as a normal part of life for many students…
Capability of advising patients…?
http://www.lycaeum.org/research/researchpdfs/1996_webb_1.pdf
CPC24: Week Overview
2013 Term 2 CPC 4 Title: Hepatobiliary 2/2
System: Hepatobiliary & Pancreas
Aim: To train students in:
Understanding of & clinical approach to diagnosis of
patients with obstructive jaundice & gall bladder disease.
Objectives: 1. History taking & clinical examination
2. Physical examination for liver, gall bladder, jaundice.
3. Pathophysiology of obstructive jaundice.
4. Review of Basic sciences: Bile synthesis and
metabolism.
5. Professional, ethical & legal issues.
6. Epidemiology, Public Health.
75
HBS:
Common
Clinical Presentations.
Why!
Biliary Obstructions:
• Extrahepatic Obstruction:
– Dislodged gallstones
– Ca. CBD, Ca. Head of pancreas.
– inflammatory stricture of CBD
– accidental surgical ligation of CBD.
• Intrahepatic Obstruction:
– Biliary atresia – Congenital.
– Primary Biliary Cirrhosis
– Primary Sclerosing Cholangitis.
– Cystic fibrosis.
Common Disorders:
• Cholecystitis
• Cholelithiasis
• Choledocholithiasis.
(Adeno Carcinoma)
95% - Cholelithiasis (+cystitis)
Cholelithiasis:
• Morphology & Types:
– Mixed Chol (Ca+Bile salt)* Multiple,
faceted, yellow-grey - commonest.
– Rarely Pure cholesterol: Round spiky.
– Bile Pigment stones (black/brown).
Infection / Jaundice. % Calcium = radio
opaque.
Complications of Cholelithiasis:
• Obstruction
• Sec biliary cirrhosis*
• Cholecystitis
• Cholangitis
• Biliary colic
• Jaundice
• Empyema
• Liver abscess
• Mucocele
• Pancreatitis.
• Peritonitis
• Carcinoma
• Fistula formation
• Gall stone ileus.
Gallstone ileus
Acute Cholecystitis:
• 90% Cholelithiasis. 10% non-calculous
• Females common.
• Outflow obstruction by a small gallstone.
• Infection – E.coli.  Empyema.
• Risk of perforation, peritonitis, fistula
 Gall stone ileus when stone enters GIT.
• Serum amylase normal (high with pancreatitis).
• Mild jaundice in 20% - obstructive.
• Acute inflammation, hemorrhage, edema, neutrophils.
• Gangrenous cholecystitis: when obstruction is severe
compromising blood supply. Green-black necrotic.
Chronic Cholecystitis:
• Females.
• Recurrent / Chronic.
• Thick fibrotic wall.
• Thick bile – biliary gravel.
• Aschoff-Rokitansky sinuses –
diverticula - Due to increased
luminal pressure (obstruction)
• Diffuse infiltration by chronic
inflammatory cells.
Acute Hemorrahagic Pancreatitis - Clinical
Severe
Mild
Grey Turner Sign - Cullen’s Sign
SUMMARY:
Trypsin  Kallikrein  Thrombosis - Necrosis
Protease  Blood Vessel injury – Bleeding.
Lipase  Fat necrosis  Inflammation.
Chronic fibrosing Pancreatitis:
Acute Hemorrhagic
Acute Hemorrhagic
Chronic fibrosing
Carcinoma
Acute Hemorrhagic Pancreatitis:
Fat Necrosis
Acini Necrosis
Hemorrhage
Normal Acini
Pancreatic Ca with fibrosis (Chronic pancreatitis)
Note: dysplastic glands infiltrating into fibro (spindle cells) myxoid (pale blue) stroma.
Malignant gl.
Ca. Infiltration
Islet (normal)
Fibrous stroma
Ca Pancreas
Clinical Features
Tumour marker:
CEA & CA19–9 antigen
Trousseau syndrome
Give someone a fish and you
feed him for a day.
Teach someone to fish and you
feed him for a lifetime!
Lao Tzu
CPC25: Week Overview
2013 Term 2 CPC 5 Title: GIT 1/3
System: Gastrointestinal
Aim: To train students in:
Understanding pathology & Clinical diagnosis of patients with
upper GIT disorders.
Clinical diagnosis of Acute Abdomen
Objectives: 1. History taking & clinical examination of patients with upper
GIT symptoms.
2. Physical examination of Abdomen. Recognition of an Acute
abdomen.
3. Pathophysiology of peptic ulcer disease.
4. Pathophysiology of gastric cancer.
5. Review of Basic sciences – Anatomy & functions of upper GIT
6. Professional, Ethical & Legal issues in chronic diseases.
7. Epidemiology & Public Health issues of Helicobacter pylori.
(Australian Nobel Laureate).
8. Presentation, epidemiology & Public Health issues of acute
appendicitis. Risk factors and counseling.
Esophagus & Stomach Normal
Glandular – Gastric  Normal  Squamous Oesophagus
Dysphagia
• Dysphagia: Difficulty in swallowing.
– Odynophagia: painful swallowing – inflam, ulcer,
Carcinoma.
• Sites:
– oropharyngeal, esophageal, esophagogastric, and
paraesophageal .
• Symptoms:
– Solids – Mechanical Obstruction – tumors/strictures.
– Solids & Liquids – Motility disorders – Achalasia.
– Liquids – Pharyngeal disorders.
• Causes:
– Local, Systemic, central.
– Mechanical, neural, functional.
– ulcers, tears, webs, rings, tumors, strictures,
paralysis abnormal peristalsis. (stroke),
Esophageal Disorders:
• Reflux Oesophagitis.
• Barrett’s
• Stricture – Inflam.
• Mallory-Weiss.
• Varices
• Hernia
• Zenker diverticulum
• T-E Fistula.
• Web – IDA – P-V Sy.
Herniations
Oesophagus motility Disorders:
Hernia: 30% incidence over 50years. (mostly asymptomatic)
Achalasia: Lack of relaxation of lower sphincter.
95% 5%
Achalasia Hernia-Sliding Hernia-Rolling
Oesophagitis:
• Acute: errosive, alcohol, infection.
• Chronic: Acid reflux (GERD),
chemical, alcohol, smoking,
candida, radiation, idiopathic
(eosinophilic).
• Endoscopic view 
Microscopy:
• Acute inflammation.
• Eosinophils: Few (reflux) more in
Eosinophilic.
Candida
GORD: Clinical Classification
GORD
Heartburn
Oesophagitis
24%
Barrett’s
1%
Non-Erosive
Reflex Disease (NERD)
(normal endoscopy)
75%
Endoscopy
24-hr pH Study
AET +ve
SI +ve
AET -ve
SI +ve
AET -ve
SI –ve
? MERD
AET: Acid Exposure Index
SI: Symptom Index.
MERD: minimal change.. RD
Etiology: (LES)
• Alcohol, Tobacco,
• Obesity,
• CNS depressants,
• Pregnancy,
• Hiatal hernia
• Delayed gastric emptying
• increased gastric volume
GERD: Pathogenesis.
Normal  Hyperplasia  Dysplasia  Carcinoma
Normal
Sq. Ep.
Metaplastic
Col. Ep.
Inflammed
Sq. Ep.
Basal cell hyperplasia
Squamous Carcinoma - Adenocarcinoma.
• Less common
• Upper end
• Tobacco, diet, toxins.
• More common
• Lower end
• Reflux disease (Barretts)
Tumour
Normal
Tumour
Normal
• Acute Gastritis:
– Drugs, toxins, alcohol, Ischemia.
– Infections (H.pylori transient)
• Chronic Gastritis:
– Autoimmune: Pernicious an.
(autoantibody)
– Chem: NSAIDs, Bile reflux,
Alcohol.
– Bacterial: Helicobacter pylori.
Gastritis:
Normal ↑
← Acute
Chronic ↓
H. Pylori Gastritis - Silver stain
Bacteria over
epithelial cells
Peptic Ulcer Morphology:
• Common in duodenum than stomach (4:1)
• > 80% single ulcer
• Round small, clean,
• punched out, <2cm*.
• Radiating folds.
• Microscopy:
– Superficial necrotic layer.
– Inflammatory cells zone.
– Granulation tissue zone - B
– Collagenous scar zone - C.
Note: Radiating mucosal folds from the ulcer.. Why?
Gastric Peptic ulcer: Scar
Note: Radiating mucosal folds from the ulcer.. Why?
Barry J Marshal, 2005 Nobel Prize….!
There were a lot of people who
didn't believe what we said but
they couldn't keep us quiet…!
A.A.Press.. 4 Oct 2005.
Barry J. Marshall & J. Robin Warren
was a trainee at that time…..!
Gastric Adeno Carcinoma:
Intestinal Type
• H.pylori Metaplasia
• C. gastritis / atrophy
• HER-2/NEU mutation
• Well differentiated
• No Signet ring cells.
• Gland formation.
• Better Prognosis
Diffuse Type
• Idiopathic/familial.
• No precursor lesion
• E-Cadherin mutations
• Poorly differentitated
• Signet ring cells
• No gland formation,
• Poor Prognosis
Fungating Carconoma
Diffuse Ca - Fibrotic
Linitis Plastica / Leather bottle stomach.
Malignant cells between fibrous stroma 
Endoscopy
Gastric Carcinoma
Malignant
Normal Gland
To attain knowledge, add
things every day.
To attain wisdom, remove
things every day.
Lao Tzu
CPC26: Week Overview
2013 Term 2 CPC 6 Title: GIT3/3
System: GIT.
Aim: To train students in:
Understanding pathology & Clinical diagnosis of patients
with lower GIT Conditions including Bowel Cancer &
Inflammatory bowel disorders.
Objectives:
(breakdown of Aim)
1. Physical examination of abdomen.
2. Review of basic sciences – Lower GIT structure &
function.
3. Pathology & Epidemiology of inflammatory bowel
disease.
4. History taking & clinical examination of patients with
Lower GIT Malignancy.
5. Genetic basis of colonic neoplasms.
6. Review of Basic sciences – Carcinogenesis, Knudson
theory, hereditary syndromes of colon cancer.
7. Professional, Ethical & Legal issues in malignancies.
8. Epidemiology & Public Health issues of lower GIT
malignancies (Global & Australian)
Etiology: Exact etiology not known…
“Unregulated and exaggerated
local immune response to Gut
flora in genetically susceptible
individuals”
• Etiology theory:
– 1. Genetic susceptibility
– 2. Environmental Factor:
Gut flora.
– 3. Immune
dysfunction/Autoimmunity.
• 15% family history, 30-59%
concordance in twins.
• HLA: DR1B1 (UC), DR7, DQ4
(CD) - 27%
• Hygiene hypothesis *
NOD2
Caspase
TNF, IL1, IL6,
IL23 R
Whole of GIT
Only Colon
Crohn’s - vs - U. Colitis:
• Chronic granulomatous.
• Transmural – full thickness.
• Ulcers deep, narrow.
• Firm thick, narrow lumen.
• Fibrosis - significant.
• Skip Lesions & fistula
• Rectal bleeding 100%
• No significant perianal sores.
• Malabsorption - Fat (ileum)
• HLA-DR7, DQ4. IL17 - TH1 cells.
• Acute infl – edema.
• Superficial - mucosal
inflammation.
• Ulcers shallow, broader.
• Normal/Thin wall, dilated lumen.
• Fibrosis - no/little.
• Continuous, no fistula.
• Rectal bleeding 75-85%
• perianal sores in 25-35%
• Malabsorption – no
• HLA – DRB1, - TH2 cells.
NOD2* IL-23R*
Crohn’s Disease: microscopy
Lymphocytes
Granuloma
Giant cells
No caseation.
UC - inflammation limited to mucosa,
atrophy of colonic glands, normal muscle layer.
Normal submucosa.
Diverticulosis:
• Later age. (>30y)
• Constipation alternating with
diarrhoea.
• Two types:
– Acquired / False common, no
muscular layer.
– True rare, congenital, all layers
present. E.g. Meckles.
Intestinal Obstructions:
• Mechanical Obstruction: (commonest)
– Adhesions, Hernias, Intussusception, Volvulus.
• Others:
– Tumors, gallstones, fecaliths, foreign bodies, Congenital stricture, atresias,
Meconium in cystic fibrosis.
Pseudomembranous Colitis:
Clostridium difficile: Controlled by normal flora. Antibiotic
therapy may result in over growth of cytotoxin producing
strains causing fibrinopurulent debris and mucus tightly
adherent to ulcerated mucosa (pseudomembran).
Polyps of Colon:
Villous
Adenoma
Tubular
Adenoma
Hyperplastic
Polyp Adeno-
Carcinoma
Polyps of Colon:
Hyperplastic - 90% - no/low malignant potential Tubular Adenoma 9% - malignant potential
Villous Adenoma 1% high malignant potential Tubulovillous Adenoma - mixed
Hereditary Colon Cancer Sy. *Rare
• HNPCC (Lynch Syndrome) (10%).
– AD, Mutation in DNA mismatch repair genes MMR
– increased risk of GI and non-GI cancers
– Few adenomatous polyps.
• Familial Adenomatous Polyposis (1%).
– AD, mutation in APC gene on 5q21
– >100 - 2500 polyps throughout GIT duodenum*
– virtually 100% risk of carcinoma by 50years.
Pathogenesis 1. – Adenoma Ca Path
More common – 70%
Pathogenesis 2. – Mismatch pathway
(also in sporadic Right type).
Less common – 10-15%
Left sided Ca Colon –
Constricting –
Napkin ring (Gross)
Apple core (Xray)
Adeno Carcinoma / Normal
Ca Colon – Dukes Staging - Prognosis.
“When we accept without
questioning, we forfeit the power to
control our own lives"
Bryce Courtenay
knowledge is power and ignorance is enslavement.
To question is the key to learning…!
CPC27: Week Overview
2013 Term 2 CPC 7 Title: Head and Neck 1/1
System: Respiratory Tract
Aim: To train students in clinical approach & diagnosis of
patients with symptoms of Upper Respiratory Tract
Infection (URTI).
Objectives: 1. History taking & clinical examination in Patients with
URTI.
2. Physical examination of head & neck.
3. Pathophysiology and Microbiology of URT & URTIs
4. Review of Basic sciences – Anatomy of Head &
Neck.
5. Professional, Ethical & Legal issues.
6. Epidemiology, Public Health.
Leukoplakia - Erythroplakia
Leuko+Erythroplakia
Erythroplakia
Leukoplakia
Progression of oral neoplasia
C
Cigarette, Alcohol & Tobacco.
Dental Pathology:
• Caries:
– Tooth decay, Mineral dissolution acid, carbs,
bacteria.
– Role of fluoride and oral hygiene
• Gingivitis:
– Junctional mucosa, hygiene.
Plaque/calculus.
– Inflammation of soft tissue around the teeth
• Periodontitis:
– Inflam. of supp. structures.
– Important in IE, pulmonary and brain
abscess
Oral Pathology:
• Irritation Fibroma:
– Fibrous scar, Rx excision
– Along bite line or a gingivo-dental
margin
• Pyogenic granuloma:
– Chronic ginvitis. Children,
pregnancy.
• Aphthous ulcers:
– Common, painful, shallow ulcers,
cause obscure.
• Glossitis:
– Trauma, dentures,
– Infections – herpes, candida,
syphilis
– Anemia – IDA, Meg.
Nasal Polyp (inflammatory):
• Chronic/recurrent URTI
• Allergy, hypersensitivity
• Mucosal inflam. Polyp
• Eosinophils.
Laryngeal Neoplasms:
• Vocal cord nodules:
singers/smokers nodules. Irritation,
Fibrous, may bleed, no malignancy.
• Recurrent (Juvenile) Papillomatosis:
children, multiple HPV (6,11).
• Single papillomas in adults.
• Laryngeal Carcinoma: Persistent
hoarseness of voice. Smokers (less
with alcohol, radiation). Vocal cords,
SCC usu. (95%)
Nasopharyngeal Carcinoma
• Africa (children) & China
(adults)...!
• EBV, Diet, likely
environment important.
• Undifferentiated
carcinoma with plenty of
reactive lymphocytes.
• Can be keratinising SCC,
non keratinising SCC and
undiff Ca
• Locally invasive, spread.
• 50% 3y survival.
Sialadenitis:
• Acute / chronic, Traumatic, viral, bacterial, autoimmune,
• xerostomia  infections.
• Parotid most common.
• Complications – calculus (sialolithiasis) or fibrosis 
duct obstruction  Recurrent sialadenitis.
• Mumps, Sjogren’s (autoimmune), S aureus, S viridans.
Pleomorphic Adenoma
• Mixed tumor, Most common (60%)
• Adults, Slow growing, Asymptomatic.
• Single, Irregular, nodular, Well defined
borders, less mobile.
• Mature Epithelial & connective tissue.
• Recurrence common.
Other tumours:
• Warthin’s tumour (lymphoepithelioma)
• Mucoepidermoid Ca.
• Adenoid cystic carcinoma
• Adeno / Squamous Cell Ca.
Education must award
character & self-confidence,
the courage to depend on
one’s own strength.
- Sai Baba

Mais conteúdo relacionado

Mais procurados

Mais procurados (20)

Respiratory lectures
Respiratory lecturesRespiratory lectures
Respiratory lectures
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
 
Hemolytic anemia sandip
Hemolytic anemia sandipHemolytic anemia sandip
Hemolytic anemia sandip
 
Red Blood cell pathology
Red Blood cell pathologyRed Blood cell pathology
Red Blood cell pathology
 
Approach to hemolytic anemia
Approach to hemolytic anemiaApproach to hemolytic anemia
Approach to hemolytic anemia
 
Pathology of immune system
Pathology of immune systemPathology of immune system
Pathology of immune system
 
Renal Pathology Lectures_Ppt Series (4 in 1)
Renal Pathology Lectures_Ppt Series (4 in 1)Renal Pathology Lectures_Ppt Series (4 in 1)
Renal Pathology Lectures_Ppt Series (4 in 1)
 
Approach to pancytopenia .Dr ABHIJEET BARUA MD PGT.KOL.MED.CLG.
Approach to pancytopenia  .Dr ABHIJEET BARUA MD PGT.KOL.MED.CLG.Approach to pancytopenia  .Dr ABHIJEET BARUA MD PGT.KOL.MED.CLG.
Approach to pancytopenia .Dr ABHIJEET BARUA MD PGT.KOL.MED.CLG.
 
White blood cell disorders
White blood cell disordersWhite blood cell disorders
White blood cell disorders
 
Haem13 hemolytic anemia - acquired
Haem13 hemolytic anemia - acquiredHaem13 hemolytic anemia - acquired
Haem13 hemolytic anemia - acquired
 
Renal pathology
Renal pathologyRenal pathology
Renal pathology
 
Myeloproliferative disorders
Myeloproliferative disordersMyeloproliferative disorders
Myeloproliferative disorders
 
Hematology mnemonics
Hematology mnemonicsHematology mnemonics
Hematology mnemonics
 
Megaloblastic anemia
Megaloblastic anemiaMegaloblastic anemia
Megaloblastic anemia
 
Chronic Myeloproliferative Disorder
Chronic Myeloproliferative DisorderChronic Myeloproliferative Disorder
Chronic Myeloproliferative Disorder
 
Chronic leukemias
Chronic leukemiasChronic leukemias
Chronic leukemias
 
Haematology
HaematologyHaematology
Haematology
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
 
Hemopoiesis[med]
Hemopoiesis[med]Hemopoiesis[med]
Hemopoiesis[med]
 
Haemopoisis and Histology of Bone Marrow
Haemopoisis and Histology of Bone MarrowHaemopoisis and Histology of Bone Marrow
Haemopoisis and Histology of Bone Marrow
 

Destaque (18)

Case stuies in Lymphomas
Case stuies in LymphomasCase stuies in Lymphomas
Case stuies in Lymphomas
 
Pathology of cns
Pathology of cnsPathology of cns
Pathology of cns
 
4 immunology-csbrp
4 immunology-csbrp4 immunology-csbrp
4 immunology-csbrp
 
Amyloidosis
AmyloidosisAmyloidosis
Amyloidosis
 
Anemia3 Hemolytic acquired
Anemia3 Hemolytic acquiredAnemia3 Hemolytic acquired
Anemia3 Hemolytic acquired
 
Pathology of Prostate
Pathology of ProstatePathology of Prostate
Pathology of Prostate
 
Rbc disorders 1
Rbc disorders 1Rbc disorders 1
Rbc disorders 1
 
Diseases Of Wbc
Diseases Of WbcDiseases Of Wbc
Diseases Of Wbc
 
4 hemostasis&amp;thrombosis
4 hemostasis&amp;thrombosis4 hemostasis&amp;thrombosis
4 hemostasis&amp;thrombosis
 
6 immunology-csbrp
6 immunology-csbrp6 immunology-csbrp
6 immunology-csbrp
 
Leucocyte Disorders - Case studies
Leucocyte Disorders - Case studiesLeucocyte Disorders - Case studies
Leucocyte Disorders - Case studies
 
Rbc disorders-4
Rbc disorders-4Rbc disorders-4
Rbc disorders-4
 
Single genedisorders 1
Single genedisorders 1Single genedisorders 1
Single genedisorders 1
 
14 wbc
14 wbc14 wbc
14 wbc
 
Haematology for Dental Students - WBC Disorders
Haematology for Dental Students - WBC DisordersHaematology for Dental Students - WBC Disorders
Haematology for Dental Students - WBC Disorders
 
Congenital wbc disorders
Congenital wbc disordersCongenital wbc disorders
Congenital wbc disorders
 
Pathology of Glomerulonephritis
Pathology of GlomerulonephritisPathology of Glomerulonephritis
Pathology of Glomerulonephritis
 
Module 8a spirochetes
Module 8a  spirochetesModule 8a  spirochetes
Module 8a spirochetes
 

Semelhante a Pathology of Anemia and Hematological Malignancies

laboratorydiagnosisofanemiaugs-170319165804 (1).pptx
laboratorydiagnosisofanemiaugs-170319165804 (1).pptxlaboratorydiagnosisofanemiaugs-170319165804 (1).pptx
laboratorydiagnosisofanemiaugs-170319165804 (1).pptxDebdattaMandal3
 
Lab. Diagnosis of Anemia.pptx
Lab. Diagnosis of Anemia.pptxLab. Diagnosis of Anemia.pptx
Lab. Diagnosis of Anemia.pptxJohn Doe
 
Laboratory diagnosis.ppt and clincal diagnosis
Laboratory diagnosis.ppt and clincal diagnosisLaboratory diagnosis.ppt and clincal diagnosis
Laboratory diagnosis.ppt and clincal diagnosisAmanyHamed15
 
Approach to pancytopenia.pptx
Approach to pancytopenia.pptxApproach to pancytopenia.pptx
Approach to pancytopenia.pptxAnimesh Debbarma
 
Anemia Lecture for the MLT students.pptx
Anemia Lecture for the MLT students.pptxAnemia Lecture for the MLT students.pptx
Anemia Lecture for the MLT students.pptxTariqAlyamani2
 
Making the diagnosis in hematology
Making the diagnosis in hematologyMaking the diagnosis in hematology
Making the diagnosis in hematologyfracpractice
 
Blood and its components Part 2
Blood and its components Part 2Blood and its components Part 2
Blood and its components Part 2Arun Panwar
 
Understanding the full blood count in 15mins - A quick lit review
Understanding the full blood count in 15mins - A quick lit reviewUnderstanding the full blood count in 15mins - A quick lit review
Understanding the full blood count in 15mins - A quick lit reviewSimon Daley
 
LEUKEMIC DISEASES AND THE EYE.pptx. This talks about the ocular manifestation...
LEUKEMIC DISEASES AND THE EYE.pptx. This talks about the ocular manifestation...LEUKEMIC DISEASES AND THE EYE.pptx. This talks about the ocular manifestation...
LEUKEMIC DISEASES AND THE EYE.pptx. This talks about the ocular manifestation...BARNABASMUGABI
 
Hematology review '04
Hematology review '04Hematology review '04
Hematology review '04coolboy101pk
 
HEM_ANEMIA_1.ppt
HEM_ANEMIA_1.pptHEM_ANEMIA_1.ppt
HEM_ANEMIA_1.pptsalah631858
 

Semelhante a Pathology of Anemia and Hematological Malignancies (20)

laboratorydiagnosisofanemiaugs-170319165804 (1).pptx
laboratorydiagnosisofanemiaugs-170319165804 (1).pptxlaboratorydiagnosisofanemiaugs-170319165804 (1).pptx
laboratorydiagnosisofanemiaugs-170319165804 (1).pptx
 
CLL. CML.pptx
CLL. CML.pptxCLL. CML.pptx
CLL. CML.pptx
 
Lab. Diagnosis of Anemia.pptx
Lab. Diagnosis of Anemia.pptxLab. Diagnosis of Anemia.pptx
Lab. Diagnosis of Anemia.pptx
 
Anemia.pdf
Anemia.pdfAnemia.pdf
Anemia.pdf
 
Laboratory diagnosis of anemia
Laboratory diagnosis of anemiaLaboratory diagnosis of anemia
Laboratory diagnosis of anemia
 
is-Anemia.pptx
is-Anemia.pptxis-Anemia.pptx
is-Anemia.pptx
 
Laboratory diagnosis.ppt and clincal diagnosis
Laboratory diagnosis.ppt and clincal diagnosisLaboratory diagnosis.ppt and clincal diagnosis
Laboratory diagnosis.ppt and clincal diagnosis
 
Haematology for Dental Students - RBC Disorders
Haematology for Dental Students - RBC DisordersHaematology for Dental Students - RBC Disorders
Haematology for Dental Students - RBC Disorders
 
Approach to pancytopenia.pptx
Approach to pancytopenia.pptxApproach to pancytopenia.pptx
Approach to pancytopenia.pptx
 
Anemia Lecture for the MLT students.pptx
Anemia Lecture for the MLT students.pptxAnemia Lecture for the MLT students.pptx
Anemia Lecture for the MLT students.pptx
 
Approach to anemia
Approach to anemiaApproach to anemia
Approach to anemia
 
Anaemia pathology ppt
Anaemia pathology pptAnaemia pathology ppt
Anaemia pathology ppt
 
Making the diagnosis in hematology
Making the diagnosis in hematologyMaking the diagnosis in hematology
Making the diagnosis in hematology
 
Blood and its components Part 2
Blood and its components Part 2Blood and its components Part 2
Blood and its components Part 2
 
Understanding the full blood count in 15mins - A quick lit review
Understanding the full blood count in 15mins - A quick lit reviewUnderstanding the full blood count in 15mins - A quick lit review
Understanding the full blood count in 15mins - A quick lit review
 
LEUKEMIC DISEASES AND THE EYE.pptx. This talks about the ocular manifestation...
LEUKEMIC DISEASES AND THE EYE.pptx. This talks about the ocular manifestation...LEUKEMIC DISEASES AND THE EYE.pptx. This talks about the ocular manifestation...
LEUKEMIC DISEASES AND THE EYE.pptx. This talks about the ocular manifestation...
 
13 rbc
13 rbc13 rbc
13 rbc
 
Hematology review '04
Hematology review '04Hematology review '04
Hematology review '04
 
L8 cml
L8 cmlL8 cml
L8 cml
 
HEM_ANEMIA_1.ppt
HEM_ANEMIA_1.pptHEM_ANEMIA_1.ppt
HEM_ANEMIA_1.ppt
 

Mais de Shashidhar Venkatesh Murthy

Pathology of STD - Sexually Transmitted Disorders
Pathology of STD -  Sexually Transmitted DisordersPathology of STD -  Sexually Transmitted Disorders
Pathology of STD - Sexually Transmitted DisordersShashidhar Venkatesh Murthy
 
Haematology for Dental Students - Bleeding Disorders
Haematology for Dental Students - Bleeding DisordersHaematology for Dental Students - Bleeding Disorders
Haematology for Dental Students - Bleeding DisordersShashidhar Venkatesh Murthy
 

Mais de Shashidhar Venkatesh Murthy (20)

Anemia 4 hemolytic congenital
Anemia 4 hemolytic congenitalAnemia 4 hemolytic congenital
Anemia 4 hemolytic congenital
 
Anemia2 deficiency anemias
Anemia2 deficiency anemiasAnemia2 deficiency anemias
Anemia2 deficiency anemias
 
Anemia5 anemias minor
Anemia5 anemias minorAnemia5 anemias minor
Anemia5 anemias minor
 
Anemia1-Case Introduction
Anemia1-Case IntroductionAnemia1-Case Introduction
Anemia1-Case Introduction
 
Pathology of Prostate - Cancer
Pathology of Prostate - CancerPathology of Prostate - Cancer
Pathology of Prostate - Cancer
 
Pathology of Prostate - Benign
Pathology of Prostate - BenignPathology of Prostate - Benign
Pathology of Prostate - Benign
 
Pathology of Urinary Tract Infectionws
Pathology of Urinary Tract InfectionwsPathology of Urinary Tract Infectionws
Pathology of Urinary Tract Infectionws
 
Pathology of Testes tumours
Pathology of Testes tumoursPathology of Testes tumours
Pathology of Testes tumours
 
Pathology of STD - Sexually Transmitted Disorders
Pathology of STD -  Sexually Transmitted DisordersPathology of STD -  Sexually Transmitted Disorders
Pathology of STD - Sexually Transmitted Disorders
 
Haem11 Anemia Introduction.
Haem11 Anemia Introduction.Haem11 Anemia Introduction.
Haem11 Anemia Introduction.
 
Haem14: Hemolytic anemia Congenital
Haem14: Hemolytic anemia CongenitalHaem14: Hemolytic anemia Congenital
Haem14: Hemolytic anemia Congenital
 
Haem12: Deficiency anemias
Haem12: Deficiency anemiasHaem12: Deficiency anemias
Haem12: Deficiency anemias
 
Pathology Lecture - Neoplasia
Pathology Lecture - NeoplasiaPathology Lecture - Neoplasia
Pathology Lecture - Neoplasia
 
Pathology of COPD
Pathology of COPDPathology of COPD
Pathology of COPD
 
Haematology for Dental Students - Bleeding Disorders
Haematology for Dental Students - Bleeding DisordersHaematology for Dental Students - Bleeding Disorders
Haematology for Dental Students - Bleeding Disorders
 
Breast Pathology Lecture - 2013
Breast Pathology Lecture - 2013Breast Pathology Lecture - 2013
Breast Pathology Lecture - 2013
 
Pathology Review-Term4
Pathology Review-Term4Pathology Review-Term4
Pathology Review-Term4
 
Pathology Review-Term3
Pathology Review-Term3Pathology Review-Term3
Pathology Review-Term3
 
Pathology Review-Term1
Pathology Review-Term1Pathology Review-Term1
Pathology Review-Term1
 
Pathology of Diabetes
Pathology of DiabetesPathology of Diabetes
Pathology of Diabetes
 

Último

Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 

Último (20)

Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 

Pathology of Anemia and Hematological Malignancies

  • 1. As is our Pathology, so is our Practice. -- Sir William Osler, M.D. (Father of Modern Medicine & Founding professor of John Hopkins, developed first residency program for physicians.) Pathology: The science of medicine !
  • 2. CPC21: Week Overview 2013 Term 2 CPC 1 Title: Haematopoetic 1/2 Anaemia System: Haematopoietic system Aim: To train students in: Clinical, pathological & population studies of patients with anemia (RBC disorders) Objectives: 1. History taking & clinical examination of patients with anaemia 2. Physical examination for anaemia and related illnesses. 3. Pathophysiology of common and important rare causes of anaemia, particularly in the tropics and Indigenous populations. 4. Review of Basic sciences relating to bone marrow, red blood cell production and turnover of iron, routine blood test parameters, measurement of iron stores, and precursors important for red cell production. 5. Pathophysiology of acute anaemic processes. 6. Complications of anaemia. 7. Anaemia as a presentation for other pathologies and as an illness in itself.
  • 3. Core Learning Issues: • Basic Science Review: –RBC life cycle, structure, functions. –Iron, B12 & Folate, Hemoglobin/bilirubin metabolism. • Major Learning: –CBC – Principles & Interpretation (reticulocytes). –Microcytic, Macrocytic & Normocytic anemia. –Overview & Classification of Anemias –Common An: IDA, MA, Hemolytic & ACD •Minor Learning: –Congenital anemia– sickle, thalassaemia, G6PD, HS. –Aplastic and hypoplastic anemia. –Disorders of excess RBC – Polycythemia. –Myelodysplastic syndromes (refractory anemia). 3
  • 5. 5
  • 6. Blood Smear - Normal 6 Lymphocyte RBC crenated RBC
  • 7. Blood count - C.B.C / F.B.C • Haemoglobin - 15±2.5, 14 ±2.5 - gms/dl. • PCV/HCT - 0.47 ±0.07, 0.42 ±0.05 - lit/lit (%) – RBC vol – better than Hb for anemia diagnosis. • RBC count - 5.5 ±1, 4.8 ± 1 x1012/lit • MCHC - Hb/PCV - 30-36 – grams/deci lit. – Hb synthesis within RBC • MCH - Hb/RBC - 29.5 ± 2.5 pg picogram (wt) – Average Hb in RBC • MCV - PCV/RBC 85 ± 8 – fl femto litres (vol) 7 30 33 85
  • 8. Reticulocyte: Immature RBC Reticular RNA - Methylene blue stain. Reticulocyte RBC Reticulocytes (Immature RBC)  Increased RBC production Reticulocytosis  Hemolytic anemia/bleeding 5-7 days (Bluish, Large (high MCV)
  • 9. MCV Microcytic Normocytic Macrocytic Measure Ferritin Low Normal/high Iron def Anemia Anemia of chronic disease/ Congenital Hb dis. Reticulocyte count high low Anemia of chronic disease Renal failure Marrow failure Hemolytic anemia or blood loss Measure B12 + folate Megaloblastic anemia Normal Low Anemia clinical Types & Diagnosis
  • 10. Haemopoiesis in Def. anemias 10 Iron Def. Anem Normal Megaloblastic Normal DNA, Low Hb More cell division Micro-Normoblasts Low DNA, Normal Hb Less Cell division Megaloblasts Normal DNA & Hb Normal cell division Normoblasts Macropoly, pancytopenia
  • 11. IDA – Clinical Features 11 Bald Fissured - Glossitis Angular chelitis Pale creases …Why?
  • 12. Stages of Iron Deficiency: 12
  • 14. Megaloblastic Anaemia: 14 Marrow Hyperplasia Erythroblasts - Megaloblasts Giant metamyelocyte - Macropolycyte Megaloblastic marrow
  • 15. 15 ANEMIA OF CHRONIC DISEASE: • Defective iron transfer. • By Inflammatory mediators. •  erythropoietin production. •  Iron transfer. • IDA with normal or increased iron stores. • Does not respond to hematenic therapy. • Responds to erythropoietin or resolution of inflammation.
  • 16. “The future belongs to those who believe in the beauty of their dreams.” –Eleanor Roosevelt
  • 17. Self-pity is an opiate! --Napoleon Hill
  • 18. Hemolytic anemia: Morphology • Abnormal shapes (here a spherocyte) • Polychromatophil (large, bluish, no central palor) • Nucleated RBC (small, pyknotic) 18 Thalassemia
  • 19. Hemolytic Anemia - Types: • Acquired/External causes: – Immune Hemolytic Anemia • Warm Antibody HA (WAHA) & Cold Ab (CAHA) • Allo immune hemolytic anemia. – Mechanical Damage • Valve, Microangiopathy (DIC), prosthesis, march – Infection induced • Clostridia, malaria, septicemia • Congenital/Internal Defects • Membrane (Hereditary Spherocytosis) • Enzyme defect (G6PD deficiency) • Hb defects (Qual: Sickle cell dis, Quant: Thalassemias) 19 1 2 3 Commonest
  • 20. Autoimmune Hemolytic An: AIHA • Auto antibody binding to red cell surface antigens / Drug complex. • RBC phagocytosis in spleen or complement fixation and intravascular hemolysis. • Warm (IgG) & Cold (IgM) types. • Warm: Drugs, Ideopathic. • Cold: Infections, Lymphoma • Lab diagnosis: Coombs Test, Direct / Indirect. 20 Warm / IgG Cold / IgM
  • 21. AIHA: Lab diagnosis – Coombs test. 21 Direct Coombs Test: (for antigen on patient RBC) Indirect Coombs Test: (for antibodies in the serum.) Pos Neg
  • 22. Sickle Cell Anemia - Pathology
  • 23. Sickle Cell Anemia • Commonest congenital hemolytic anemia. • Hemoglobinopathy – β chain 6(ValGlu)  HbS • Deoxigenation  cryst. Hb  rigid sickle  obstruction, hemolysis. • BS - Sickle cells, anisocytosis, poikilocytosis, and target cells. • Hemolytic anemia, Multiple Infarcts, autosplenectomy(adult), pigment gall stones, hemosiderosis.
  • 24. Thalassemia: 24 • Quantitative Hb defect. • Defective protein chain synthesis. • α, β, , , … types. • α thal  α  Hb   β (β β or β tetramers) • Decreased normal Hb. • Abnormal Hb (α/β tetramers). • Like IDA (minor) Destruction  hemolytic anemia (major) • Minor: micro hypo, target cells • Major: severe with hemolysis. Minor / Trait Major / Disease
  • 25. “The only person who never makes a mistake is a person who never does anything” - Theodore Roosevelt 25
  • 26. 2013 Term 2 CPC 2 Title: Haematology 2/2 System: Haematopoetic System Aim: To train students in: Clinical and pathological presentation of haematological malignancy Objectives: 1. History taking & clinical examination of patients with haematological malignancy 2. Physical examination of haematopoeitic system and related systems in malignancy. 3. Pathophysiology of haematological malignancies. 4. Review of basic sciences relating to bone marrow, red blood cell production and turnover of iron, routine blood test parameters, measurement of iron stores, and precursors important for red cell production. 5. Pathophysiology 6. Complications of haematological malignancies. CPC22: Week Overview
  • 27. 27 Normal Blood Cells: Neutrophil Basophil Eosinophil Lymphocyte Non granular, Mononuclears Specific Immunity Granulocytes, Polymorphs Non-Specific Immunity
  • 28. WBC Absolute counts in disease: Penia Philia Neutro Penia Philia Eosino Penia cytosis Mono Penia cytosis Lympho
  • 29. Granulopoiesis – Leukocytosis – Shift to left
  • 30. Leukemia Classification • Acute Leukemias: – Acute Myeloid Leukemia - AML • AML M0, M1, M2, M3, M4, M5, M6 & M7 – Acute Lymphoid Leukemia - ALL • ALL - L1, L2 & L3 - maturity • Chronic Leukemias: – Chronic Myeloid Leukemia- CML • Eosinophilic, neutrophilic, myelomonocytic etc. – Chronic Lymphoid Leukemia - CLL • Myeloma, Hairy cell, prolymph, Sezary sy. etc.
  • 32. Leukemia - Clinical Features Decreased Hemopoiesis: • Anemia (low RBC) • Fever - Infections (low WBC) • Bleeding tendency (low PLT) Organ Infiltration: • Bone pain / back pain. • Lymphadenopathy. • Hepato-spleenomegaly.
  • 33. ALL - AML • Dense chromatin • Few nucleoli • Scanty cytoplasm. • No cytoplasmic granules. • Fine lacy chromatin • Many nucleoli • More cytoplasm • Cytoplasmic granules
  • 34. CML CLL • Middle age 40-60y • Philadelphia chrom. t(9:22) • Anemia, Fever & Bleeding • Marked leucocytosis – >50,000 (abnormal) • Marked splenomegaly, Hepatomegaly. • Elderly age • Anemia, fever & bleeding – slow over years. • Lymphocytosis & Lymphadenopathy • Marked Spleenomegaly • Common B cell (CD5 +ve) Chronic phase Accelerated crisis Clinical course 
  • 35. Lymphoma • Definition: Neoplasms of lymphoid tissue • Etiology: Idiopathic, Genetic, Infective. • Pathogenesis: – overexpression of antiapoptotic gene – t(14-18)  bcl-2+IgM.  B Lymph. neoplasia * • Clinical: Lymphadenopathy, weight loss, Fever, Anemia. • Hodgkins lymphoma (HL) – RS cells. • Non-Hodgkins lymphoma (NHL) – no RS. – B, T & Histiocytic “B commonest”
  • 36. Hodgkins Lymphoma: • Only Reed-Sternberg cells are malignant ‘B’ cells. Others cells are reactive. • Types: • Nodular sclerosis HL • Lymphocyte-rich classical HL • Mixed cellularity HL • Lymphocyte depletion HL • More RS cells = poor prognosis. • Progresses by continuity – nearby LN first. • Staging is important for prognosis. (x NHL)
  • 37. Hodgkins Lymphoma: • B cell lymphoma with special RS cells. • Only Reed-Sternberg cells are malignant ‘B’ lymphocytes. Others cells are mixed inflammatory cells with eosinophils. • Many sub types: based on % of RS cells. • More RS cells = poor prognosis. 1. Lymphocyte-rich classical HL 2. Nodular sclerosis HL – commonest. 3. Mixed cellularity HL 4. Lymphocyte depletion HL • Spread to nearby LN not distant. • Good prognosis, cure likely* RS RS RS
  • 38. Non-Hodgkins Lymphoma: • Large group of lymphatic malignancies. • types B, T & Histiocytic. “B common” • Clinical Features: – Fever, anemia, infections, – Lymphadenopathy. Spleen+/-. – low, intermediate & high grade. • Pathology – Lymphnode tumour – no RS cells, all one type. – Follicular / Diffuse, Small / Large / mix Cells. • Special types: – Burkitts lymphoma – lymphoblastic. – Multiple Myeloma – plasma cell.
  • 39. NHL types- Diffuse & Nodular types
  • 40. Lymphoma: Hodgkins Non Hodgkins Age Average age is 27.7 with two peaks, 15-24y , >55. Average age is about 67. Occurrence ~ 15% of all lymphomas ~ 85% of all lymphomas Location above the collar bone 85% (the mediastinum), Extranodal in 4% Chest in 40%, more abdomen (exception lymphoblastic lymphoma) Extranodal in ~23% & BM Affected Lymph Cells B-Lymphocytes characterized by the Reed-Sternberg Cell B, T, Histiocytes, NK Cells depending on the subtype Symptoms More likely to have systemic ("B") Symptoms Less likely to have "B“ symptoms.(27%) Progression Early diagnosis, Predictable, continuous involvement. Better prog. Late stages, less predictable more spread. Good to Worse prognosis.
  • 41. Burkitt’s lymphoma: B cell. • Young children, EBV virus. • Endemic in Africa • High grade, fast growing, • Tumour in jaw bones. • Lymphoblastic lymphoma • Many macrophages – “starry sky” appearance.
  • 42. Multiple Myeloma: • Malignancy of Plasma cells (Mature B lymphocytes with Ab production) • Hyper gammaglobulinemia • Monoclonal antibody – neoplastic. • Thick viscous blood – infarctions, visual difficulties & even blindness. • Old age, males common. • Multiple, punched out Lytic bone lesions (Osteolysis) & fractures. • Immunodeficiency – infections.
  • 43. "Creativity is inventing, experimenting, growing, taking risks, breaking rules, making mistakes, and having fun." -- Mary Lou Cook
  • 44. MyeloProliferative Syndromes: • Neoplastic, Proliferation, Slow, chronic, & Mature cells. • JAK2 gene mutation on 9p*  Erythropoietin hypersensitivity. • Increased number (Functionally abnormal) • Extramedullary spread – Hepatosplenomegaly. • May transform to Acute Leukemia (AML). • Classification: – RBC - Polycythemia vera (PV) – WBC • Chronic Myeloid Leukemia (CML) • Chronic neutrophilic leukemia • Chronic eosinophilic leukemia/HE syndrome. – PLT - Essential Thrombocythemia (ET) – Fibroblasts - Myelofibrosis (MF)
  • 45. ET - Blood Film & clinical. Plenty of Platelets Megakaryocyte
  • 46. Polycythemia Rubra Vera (PV) Hypercellular Marrow, Red skin & Hepatosplenomegaly
  • 47. MPS : MF. Hepatosplenomegaly Massive hepato-splenomegaly secondary to Extramedullary hematopoiesis due to Myelofibrosis.
  • 48. Myelodysplastic Syndromes: • Excess proliferation & destruction of dysplastic cells in BM  Peripheral pancytopenia. • Also known as Refractory Anemia’s FAB classification RA : Refractory Anemia (BM Blasts <1%) RARS : RA with Ring Sideroblasts (<1%) RAEB : RA with excess blasts (<5%) RAEB in T : RAEB in transformation (5-30%) (>30% blasts in BM  Leukemia) Abnormal cells & Recurrent infections in MDS
  • 49. Worrying is like a rocking chair, it gives you something to do, but doesn't get you anywhere. -- Anonymous. ….Instead.. join winners club….!
  • 50. The goal of mankind is knowledge, which is is inherent in man. No knowledge comes from outside: it is all inside. What man 'learns' is really what he “discovers” by taking the cover off his own soul. Swami Vivekananda Education… from Eduse (latin) to bring out..
  • 51. 2013 Term 2 CPC 3 Title: Hepatobiliary 1/2 System: Hepatobiliary System Aim: To train students in: Clinical Diagnosis & Understanding of patients with liver disease. Objectives: (breakdown of Aim) 1. History taking & clinical examination in patients with liver disease. 2. Pathophysiology of acute & chronic hepatitis. 3. Pathophysiology of cirrhosis. 4. Review of basic sciences of hepatobiliary system. 5. Professional, ethical & legal issues in alcohol & drug abuse. 6. Epidemiology of addiction, public health strategies. CPC23: Week Overview Note to tutors: There are two cases this week. Either case illustrates the learning issues. Please feel free to use either case (or both).
  • 52. 52 Liver Function Tests: Interpretation • Synthesis / Function. – Total protein & albumin low, PT?Hepatocyte Injury. – ALT, AST, LDH - high. ?? – Alk Phos – mild increase?? • Bile Duct Damage: – Alk Phos – increased ?? • Other: – GGT – alcohol use. – why? – Viral serology - – Auto-Antibody panel. GGT ↑ Alcohol (centrilobular) IgG ↑ Autoimmune hepatitis IgM ↑ Primary biliary cirrhosis IgA ↑ Alcoholic cirrhosis AFP +ve Hep. Cell. Carcinoma Anti- mitochondrial antibody +ve Primary biliary cirrhosis Anti-smooth muscle, & ANA +ve Autoimmune hepatitis
  • 53. 53 • 1.5 kg, wedge shape • 4 lobes, Right, left, (Caudate, Quadrate) • Double blood supply • Hepatic arteries • Portal – Venous blood Normal
  • 54. CPC 4.2.3 – 2013 – “yellow eyes” • Fatigue / Anorexia..? • Nausea, Vomiting..? • Haematemesis… ? • Itching..? • Fever..? • Abdominal distension slow..? • Bleeding / Bruising..? • 10 stubbies/day /more..? • Many Tattoos..? • BMI – if low / High..? 54 Mr. T.D. 50 year old, presents to his GP. ‘My stomach appears big and my wife has noticed a yellow tinge in my eyes’. CASE STUDY 1 Abd distension, fatigue, yellow discoloration of eyes for 1 week Presenting Symptoms: • Liver failure… • Liver failure… • Portal Hypertension • Obstructive jaundice. • Hepatitis. • Cirrhosis. • Vit-K deficiency. • Alcoholic hepatitis. • Viral Hepatitis (B/C) • Anorexia / Obesity – steatosis. • Differential Diagnosis: • Hepatitis: Alcoholic/Infective/Malignant/Drug/Toxins • Acute / Chronic? Primary/Secondary? • “HBV / HCV, CMV, Lepto, Dengue, Melioidosis.
  • 56. 56 Viral Hepatitis B: Serology Sequence of serologic markers for hepatitis B viral hepatitis demonstrating (A) acute infection with resolution and (B) progression to chronic infection.
  • 58. 58 Acute Hepatitis: • Portal & Diffuse Inflammation. • No clear border between inflammation & normal tissue • Because of active necrosis & apoptosis at margins. • Abnormal enzymes.
  • 59. 59 Liver Biopsy – Chronic Inflammation • Portal Inflammation. • No Necrosis • Liver enzymes normal
  • 60. 60 Acute viral Hepatitis: Swelling & Apoptotic cells. • Diffuse Inflammation. • Necrosis & Apoptosis. • Liver enzymes raised.
  • 61. 61 Fulminant Hepatitis: • Rapid Hepatic failure with in 2-3 weeks. • Massive necrosis, shrinkage, wrinkled • Only portal tracts visible • Little or massive inflammation – time • Complete recovery – or - cirrhosis.
  • 62. 62 Clinical Spectrum of HBV inf: Acute Chronic
  • 63. 63 Cirrhosis – Portal hypertension 1. Cirrhosis-obstruction 2. Portal hypertension 3. Splenomegaly 4. transudation - Ascites
  • 64. 64 Liver Biopsy – Cirrhosis Reg. nodule Fibrous septa
  • 65. Primary Biliary Cirrhosis • Autoimmune. • Females 6:1. • Pruritis, jaundice, hepatosplenomegaly (initial). • Intrahepatic Bile duct inflammation • Cholestasis (bile stained liver) 65
  • 66. "The past, the present and the future are really one: they are today!" -Harriet Beecher Stowe The past has gone and future you cannot see. The present, when you can do something, that is the Gift (Present) with which you can make your future & past memorable. - Sai Baba
  • 69. 69 Alcoholic Hepatits - Mallory's hyalin
  • 73. 73 Learn from the mistakes of others. You can't live long enough to make them all yourself…! 61% of 5th year students exceeded ‘sensible’ limits Drugs and alcohol were taken mainly for pleasure and were perceived as a normal part of life for many students… Capability of advising patients…? http://www.lycaeum.org/research/researchpdfs/1996_webb_1.pdf
  • 74. CPC24: Week Overview 2013 Term 2 CPC 4 Title: Hepatobiliary 2/2 System: Hepatobiliary & Pancreas Aim: To train students in: Understanding of & clinical approach to diagnosis of patients with obstructive jaundice & gall bladder disease. Objectives: 1. History taking & clinical examination 2. Physical examination for liver, gall bladder, jaundice. 3. Pathophysiology of obstructive jaundice. 4. Review of Basic sciences: Bile synthesis and metabolism. 5. Professional, ethical & legal issues. 6. Epidemiology, Public Health.
  • 76. Biliary Obstructions: • Extrahepatic Obstruction: – Dislodged gallstones – Ca. CBD, Ca. Head of pancreas. – inflammatory stricture of CBD – accidental surgical ligation of CBD. • Intrahepatic Obstruction: – Biliary atresia – Congenital. – Primary Biliary Cirrhosis – Primary Sclerosing Cholangitis. – Cystic fibrosis. Common Disorders: • Cholecystitis • Cholelithiasis • Choledocholithiasis. (Adeno Carcinoma) 95% - Cholelithiasis (+cystitis)
  • 77. Cholelithiasis: • Morphology & Types: – Mixed Chol (Ca+Bile salt)* Multiple, faceted, yellow-grey - commonest. – Rarely Pure cholesterol: Round spiky. – Bile Pigment stones (black/brown). Infection / Jaundice. % Calcium = radio opaque.
  • 78. Complications of Cholelithiasis: • Obstruction • Sec biliary cirrhosis* • Cholecystitis • Cholangitis • Biliary colic • Jaundice • Empyema • Liver abscess • Mucocele • Pancreatitis. • Peritonitis • Carcinoma • Fistula formation • Gall stone ileus. Gallstone ileus
  • 79. Acute Cholecystitis: • 90% Cholelithiasis. 10% non-calculous • Females common. • Outflow obstruction by a small gallstone. • Infection – E.coli.  Empyema. • Risk of perforation, peritonitis, fistula  Gall stone ileus when stone enters GIT. • Serum amylase normal (high with pancreatitis). • Mild jaundice in 20% - obstructive. • Acute inflammation, hemorrhage, edema, neutrophils. • Gangrenous cholecystitis: when obstruction is severe compromising blood supply. Green-black necrotic.
  • 80. Chronic Cholecystitis: • Females. • Recurrent / Chronic. • Thick fibrotic wall. • Thick bile – biliary gravel. • Aschoff-Rokitansky sinuses – diverticula - Due to increased luminal pressure (obstruction) • Diffuse infiltration by chronic inflammatory cells.
  • 81. Acute Hemorrahagic Pancreatitis - Clinical Severe Mild Grey Turner Sign - Cullen’s Sign
  • 82. SUMMARY: Trypsin  Kallikrein  Thrombosis - Necrosis Protease  Blood Vessel injury – Bleeding. Lipase  Fat necrosis  Inflammation.
  • 83. Chronic fibrosing Pancreatitis: Acute Hemorrhagic Acute Hemorrhagic Chronic fibrosing Carcinoma
  • 84. Acute Hemorrhagic Pancreatitis: Fat Necrosis Acini Necrosis Hemorrhage Normal Acini
  • 85. Pancreatic Ca with fibrosis (Chronic pancreatitis) Note: dysplastic glands infiltrating into fibro (spindle cells) myxoid (pale blue) stroma. Malignant gl. Ca. Infiltration Islet (normal) Fibrous stroma
  • 86. Ca Pancreas Clinical Features Tumour marker: CEA & CA19–9 antigen Trousseau syndrome
  • 87. Give someone a fish and you feed him for a day. Teach someone to fish and you feed him for a lifetime! Lao Tzu
  • 88. CPC25: Week Overview 2013 Term 2 CPC 5 Title: GIT 1/3 System: Gastrointestinal Aim: To train students in: Understanding pathology & Clinical diagnosis of patients with upper GIT disorders. Clinical diagnosis of Acute Abdomen Objectives: 1. History taking & clinical examination of patients with upper GIT symptoms. 2. Physical examination of Abdomen. Recognition of an Acute abdomen. 3. Pathophysiology of peptic ulcer disease. 4. Pathophysiology of gastric cancer. 5. Review of Basic sciences – Anatomy & functions of upper GIT 6. Professional, Ethical & Legal issues in chronic diseases. 7. Epidemiology & Public Health issues of Helicobacter pylori. (Australian Nobel Laureate). 8. Presentation, epidemiology & Public Health issues of acute appendicitis. Risk factors and counseling.
  • 89. Esophagus & Stomach Normal Glandular – Gastric  Normal  Squamous Oesophagus
  • 90. Dysphagia • Dysphagia: Difficulty in swallowing. – Odynophagia: painful swallowing – inflam, ulcer, Carcinoma. • Sites: – oropharyngeal, esophageal, esophagogastric, and paraesophageal . • Symptoms: – Solids – Mechanical Obstruction – tumors/strictures. – Solids & Liquids – Motility disorders – Achalasia. – Liquids – Pharyngeal disorders. • Causes: – Local, Systemic, central. – Mechanical, neural, functional. – ulcers, tears, webs, rings, tumors, strictures, paralysis abnormal peristalsis. (stroke),
  • 91. Esophageal Disorders: • Reflux Oesophagitis. • Barrett’s • Stricture – Inflam. • Mallory-Weiss. • Varices • Hernia • Zenker diverticulum • T-E Fistula. • Web – IDA – P-V Sy. Herniations
  • 92. Oesophagus motility Disorders: Hernia: 30% incidence over 50years. (mostly asymptomatic) Achalasia: Lack of relaxation of lower sphincter. 95% 5% Achalasia Hernia-Sliding Hernia-Rolling
  • 93. Oesophagitis: • Acute: errosive, alcohol, infection. • Chronic: Acid reflux (GERD), chemical, alcohol, smoking, candida, radiation, idiopathic (eosinophilic). • Endoscopic view  Microscopy: • Acute inflammation. • Eosinophils: Few (reflux) more in Eosinophilic. Candida
  • 94. GORD: Clinical Classification GORD Heartburn Oesophagitis 24% Barrett’s 1% Non-Erosive Reflex Disease (NERD) (normal endoscopy) 75% Endoscopy 24-hr pH Study AET +ve SI +ve AET -ve SI +ve AET -ve SI –ve ? MERD AET: Acid Exposure Index SI: Symptom Index. MERD: minimal change.. RD Etiology: (LES) • Alcohol, Tobacco, • Obesity, • CNS depressants, • Pregnancy, • Hiatal hernia • Delayed gastric emptying • increased gastric volume
  • 95. GERD: Pathogenesis. Normal  Hyperplasia  Dysplasia  Carcinoma Normal Sq. Ep. Metaplastic Col. Ep. Inflammed Sq. Ep. Basal cell hyperplasia
  • 96. Squamous Carcinoma - Adenocarcinoma. • Less common • Upper end • Tobacco, diet, toxins. • More common • Lower end • Reflux disease (Barretts) Tumour Normal Tumour Normal
  • 97. • Acute Gastritis: – Drugs, toxins, alcohol, Ischemia. – Infections (H.pylori transient) • Chronic Gastritis: – Autoimmune: Pernicious an. (autoantibody) – Chem: NSAIDs, Bile reflux, Alcohol. – Bacterial: Helicobacter pylori. Gastritis: Normal ↑ ← Acute Chronic ↓
  • 98. H. Pylori Gastritis - Silver stain Bacteria over epithelial cells
  • 99. Peptic Ulcer Morphology: • Common in duodenum than stomach (4:1) • > 80% single ulcer • Round small, clean, • punched out, <2cm*. • Radiating folds. • Microscopy: – Superficial necrotic layer. – Inflammatory cells zone. – Granulation tissue zone - B – Collagenous scar zone - C. Note: Radiating mucosal folds from the ulcer.. Why?
  • 100. Gastric Peptic ulcer: Scar Note: Radiating mucosal folds from the ulcer.. Why?
  • 101. Barry J Marshal, 2005 Nobel Prize….! There were a lot of people who didn't believe what we said but they couldn't keep us quiet…! A.A.Press.. 4 Oct 2005. Barry J. Marshall & J. Robin Warren was a trainee at that time…..!
  • 102. Gastric Adeno Carcinoma: Intestinal Type • H.pylori Metaplasia • C. gastritis / atrophy • HER-2/NEU mutation • Well differentiated • No Signet ring cells. • Gland formation. • Better Prognosis Diffuse Type • Idiopathic/familial. • No precursor lesion • E-Cadherin mutations • Poorly differentitated • Signet ring cells • No gland formation, • Poor Prognosis
  • 104. Diffuse Ca - Fibrotic Linitis Plastica / Leather bottle stomach. Malignant cells between fibrous stroma  Endoscopy
  • 106. To attain knowledge, add things every day. To attain wisdom, remove things every day. Lao Tzu
  • 107. CPC26: Week Overview 2013 Term 2 CPC 6 Title: GIT3/3 System: GIT. Aim: To train students in: Understanding pathology & Clinical diagnosis of patients with lower GIT Conditions including Bowel Cancer & Inflammatory bowel disorders. Objectives: (breakdown of Aim) 1. Physical examination of abdomen. 2. Review of basic sciences – Lower GIT structure & function. 3. Pathology & Epidemiology of inflammatory bowel disease. 4. History taking & clinical examination of patients with Lower GIT Malignancy. 5. Genetic basis of colonic neoplasms. 6. Review of Basic sciences – Carcinogenesis, Knudson theory, hereditary syndromes of colon cancer. 7. Professional, Ethical & Legal issues in malignancies. 8. Epidemiology & Public Health issues of lower GIT malignancies (Global & Australian)
  • 108. Etiology: Exact etiology not known… “Unregulated and exaggerated local immune response to Gut flora in genetically susceptible individuals” • Etiology theory: – 1. Genetic susceptibility – 2. Environmental Factor: Gut flora. – 3. Immune dysfunction/Autoimmunity. • 15% family history, 30-59% concordance in twins. • HLA: DR1B1 (UC), DR7, DQ4 (CD) - 27% • Hygiene hypothesis * NOD2 Caspase TNF, IL1, IL6, IL23 R
  • 110. Crohn’s - vs - U. Colitis: • Chronic granulomatous. • Transmural – full thickness. • Ulcers deep, narrow. • Firm thick, narrow lumen. • Fibrosis - significant. • Skip Lesions & fistula • Rectal bleeding 100% • No significant perianal sores. • Malabsorption - Fat (ileum) • HLA-DR7, DQ4. IL17 - TH1 cells. • Acute infl – edema. • Superficial - mucosal inflammation. • Ulcers shallow, broader. • Normal/Thin wall, dilated lumen. • Fibrosis - no/little. • Continuous, no fistula. • Rectal bleeding 75-85% • perianal sores in 25-35% • Malabsorption – no • HLA – DRB1, - TH2 cells. NOD2* IL-23R*
  • 112. UC - inflammation limited to mucosa, atrophy of colonic glands, normal muscle layer. Normal submucosa.
  • 113. Diverticulosis: • Later age. (>30y) • Constipation alternating with diarrhoea. • Two types: – Acquired / False common, no muscular layer. – True rare, congenital, all layers present. E.g. Meckles.
  • 114. Intestinal Obstructions: • Mechanical Obstruction: (commonest) – Adhesions, Hernias, Intussusception, Volvulus. • Others: – Tumors, gallstones, fecaliths, foreign bodies, Congenital stricture, atresias, Meconium in cystic fibrosis.
  • 115. Pseudomembranous Colitis: Clostridium difficile: Controlled by normal flora. Antibiotic therapy may result in over growth of cytotoxin producing strains causing fibrinopurulent debris and mucus tightly adherent to ulcerated mucosa (pseudomembran).
  • 117. Polyps of Colon: Hyperplastic - 90% - no/low malignant potential Tubular Adenoma 9% - malignant potential Villous Adenoma 1% high malignant potential Tubulovillous Adenoma - mixed
  • 118. Hereditary Colon Cancer Sy. *Rare • HNPCC (Lynch Syndrome) (10%). – AD, Mutation in DNA mismatch repair genes MMR – increased risk of GI and non-GI cancers – Few adenomatous polyps. • Familial Adenomatous Polyposis (1%). – AD, mutation in APC gene on 5q21 – >100 - 2500 polyps throughout GIT duodenum* – virtually 100% risk of carcinoma by 50years.
  • 119. Pathogenesis 1. – Adenoma Ca Path More common – 70%
  • 120. Pathogenesis 2. – Mismatch pathway (also in sporadic Right type). Less common – 10-15%
  • 121. Left sided Ca Colon – Constricting – Napkin ring (Gross) Apple core (Xray)
  • 122. Adeno Carcinoma / Normal
  • 123. Ca Colon – Dukes Staging - Prognosis.
  • 124. “When we accept without questioning, we forfeit the power to control our own lives" Bryce Courtenay knowledge is power and ignorance is enslavement. To question is the key to learning…!
  • 125. CPC27: Week Overview 2013 Term 2 CPC 7 Title: Head and Neck 1/1 System: Respiratory Tract Aim: To train students in clinical approach & diagnosis of patients with symptoms of Upper Respiratory Tract Infection (URTI). Objectives: 1. History taking & clinical examination in Patients with URTI. 2. Physical examination of head & neck. 3. Pathophysiology and Microbiology of URT & URTIs 4. Review of Basic sciences – Anatomy of Head & Neck. 5. Professional, Ethical & Legal issues. 6. Epidemiology, Public Health.
  • 127. Progression of oral neoplasia C Cigarette, Alcohol & Tobacco.
  • 128. Dental Pathology: • Caries: – Tooth decay, Mineral dissolution acid, carbs, bacteria. – Role of fluoride and oral hygiene • Gingivitis: – Junctional mucosa, hygiene. Plaque/calculus. – Inflammation of soft tissue around the teeth • Periodontitis: – Inflam. of supp. structures. – Important in IE, pulmonary and brain abscess
  • 129. Oral Pathology: • Irritation Fibroma: – Fibrous scar, Rx excision – Along bite line or a gingivo-dental margin • Pyogenic granuloma: – Chronic ginvitis. Children, pregnancy. • Aphthous ulcers: – Common, painful, shallow ulcers, cause obscure. • Glossitis: – Trauma, dentures, – Infections – herpes, candida, syphilis – Anemia – IDA, Meg.
  • 130. Nasal Polyp (inflammatory): • Chronic/recurrent URTI • Allergy, hypersensitivity • Mucosal inflam. Polyp • Eosinophils.
  • 131. Laryngeal Neoplasms: • Vocal cord nodules: singers/smokers nodules. Irritation, Fibrous, may bleed, no malignancy. • Recurrent (Juvenile) Papillomatosis: children, multiple HPV (6,11). • Single papillomas in adults. • Laryngeal Carcinoma: Persistent hoarseness of voice. Smokers (less with alcohol, radiation). Vocal cords, SCC usu. (95%)
  • 132. Nasopharyngeal Carcinoma • Africa (children) & China (adults)...! • EBV, Diet, likely environment important. • Undifferentiated carcinoma with plenty of reactive lymphocytes. • Can be keratinising SCC, non keratinising SCC and undiff Ca • Locally invasive, spread. • 50% 3y survival.
  • 133. Sialadenitis: • Acute / chronic, Traumatic, viral, bacterial, autoimmune, • xerostomia  infections. • Parotid most common. • Complications – calculus (sialolithiasis) or fibrosis  duct obstruction  Recurrent sialadenitis. • Mumps, Sjogren’s (autoimmune), S aureus, S viridans.
  • 134. Pleomorphic Adenoma • Mixed tumor, Most common (60%) • Adults, Slow growing, Asymptomatic. • Single, Irregular, nodular, Well defined borders, less mobile. • Mature Epithelial & connective tissue. • Recurrence common. Other tumours: • Warthin’s tumour (lymphoepithelioma) • Mucoepidermoid Ca. • Adenoid cystic carcinoma • Adeno / Squamous Cell Ca.
  • 135. Education must award character & self-confidence, the courage to depend on one’s own strength. - Sai Baba